2[1]Litwin MS,Mcnaughton- Collins M,Fowler FJ,et al.The national institates of health chronic prostatitits symptom index: development and validation of a new outcome measure.J Urol,1999,162:369-375
4[3]Zabkowski T,Peterek J,Stawarz B,et al.The results of treatment chronic prostatitits on the Background fungal infections.Wiad Lek,1999,52: 456-461
5[4]Tanner MA,Shos,kes D,Shahed A,et al.Prevalence of corynebacterial 16 s rRNA sequences in Patients with bacterial And nonbacterial prostatitits.J Clin Microbiol,1999,37:1863-1870
6[5]Theodorou C,Konidaris D,Moutzouris G,et al.The urodynamic profile of prostaodynia.BJU Int,1999,84:461-463
7[6]Mark AL,Martin Brandt.Cloning,expression and functional characterization of type 1 and type 2 steroid 5α-reductases from cynomolgus monkey: comparisons with human and rat isoenzymes.J Steroid Biochem Molec Biol,1995,52:307-319
7BERCER R E.Predictors of quality of life and pain in chronic prostatitis/chronic pelvic pain syndrome:findings from the Nationa Institutes of Health Chronic Prostatitis Cohort Study[J].J Urol,2005,174(5):1842-1843.
8Schaeffer A J, Knauss JS, Landis JR, et al. I_eukocyte and bacterial counts do not correlate with severity of symptoms in men with chronic prostatitis: the National Institutes of Health Chronic Pro- statitis Cohort Study[ J]. J Urol,2002,168(3) : 1048-1053.
9Nickel JC, Nyberg LM, Hennenfent M. Research guidelines for chronic prostatitis: consensusreport from the first National Institutes of Health International Prostafitis Collaborative Network[ J]. Urolo-gy, 1999,54: 229-233.
10Buck AC,Rees RWM, Ebeling L. Treatment of chronic prostatitis and pmstatodynia with pollen extract[J]. Br J Uml, 1989,64:496- 499.
